Brian Steven Goldstein
Known title: DirectorCIK: 0001936689
Brian Steven Goldstein's purchase track record
Brian Steven Goldstein has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/9/2022 | VATE | $15K | -6.9% | +115.9% | -5.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| VATE | ▲ Buy | Grant | 12,016 | $0 | 8/11/2026 | View on chart |
| VATE | ▲ Buy | Grant | 16,363 | $0 | 6/12/2025 | View on chart |
| VATE | ▲ Buy | Grant | 161,001 | $0 | 6/18/2024 | View on chart |
| VATE | ▲ Buy | Grant | 46,392 | $0 | 6/15/2023 | View on chart |
| VATE | ▲ Buy | Grant | 108,801 | $0 | 11/4/2022 | View on chart |
| VATE | ▲ Buy | Open Market | 10,000 | $15K | 9/9/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Innovate Corp. highlighted in Zacks analyst blog
Innovate Corp. (VATE) was included in a recent Zacks analyst blog that also featured AMD, Linde and Amgen. The mention places the company among a group of well‑known peers, potentially drawing investor attention. The stock currently carries a dividend yield of 9.62% and trades within a 52‑week range of $3.75 to $21.30.
Innovate Corp. highlighted in Zacks analyst blog. Innovate Corp. (VATE) was included in a recent Zacks analyst blog that also featured AMD, Linde and Amgen. The mention places the company among a group of well‑known peers, potentially drawing investor attention. The stock currently carries a dividend yield of 9.62% and trades within a 52‑week range of $3.75 to $21.30.